Predicting adverse long-term neurocognitive outcomes after pediatric intensive care unit admission.

Label ranking Machine learning Pediatric intensive care units Personalized healthcare

Journal

Computer methods and programs in biomedicine
ISSN: 1872-7565
Titre abrégé: Comput Methods Programs Biomed
Pays: Ireland
ID NLM: 8506513

Informations de publication

Date de publication:
10 Apr 2024
Historique:
received: 28 02 2023
revised: 18 03 2024
accepted: 05 04 2024
medline: 14 4 2024
pubmed: 14 4 2024
entrez: 13 4 2024
Statut: aheadofprint

Résumé

Critically ill children may suffer from impaired neurocognitive functions years after ICU (intensive care unit) discharge. To assess neurocognitive functions, these children are subjected to a fixed sequence of tests. Undergoing all tests is, however, arduous for former pediatric ICU patients, resulting in interrupted evaluations where several neurocognitive deficiencies remain undetected. As a solution, we propose using machine learning to predict the optimal order of tests for each child, reducing the number of tests required to identify the most severe neurocognitive deficiencies. We have compared the current clinical approach against several machine learning methods, mainly multi-target regression and label ranking methods. We have also proposed a new method that builds several multi-target predictive models and combines the outputs into a ranking that prioritizes the worse neurocognitive outcomes. We used data available at discharge, from children who participated in the PEPaNIC-RCT trial (ClinicalTrials.gov-NCT01536275), as well as data from a 2-year follow-up study. The institutional review boards at each participating site have also approved this follow-up study (ML8052; NL49708.078; Pro00038098). Our proposed method managed to outperform other machine learning methods and also the current clinical practice. Precisely, our method reaches approximately 80% precision when considering top-4 outcomes, in comparison to 65% and 78% obtained by the current clinical practice and the state-of-the-art method in label ranking, respectively. Our experiments demonstrated that machine learning can be competitive or even superior to the current testing order employed in clinical practice, suggesting that our model can be used to severely reduce the number of tests necessary for each child. Moreover, the results indicate that possible long-term adverse outcomes are already predictable as early as at ICU discharge. Thus, our work can be seen as the first step to allow more personalized follow-up after ICU discharge leading to preventive care rather than curative.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Critically ill children may suffer from impaired neurocognitive functions years after ICU (intensive care unit) discharge. To assess neurocognitive functions, these children are subjected to a fixed sequence of tests. Undergoing all tests is, however, arduous for former pediatric ICU patients, resulting in interrupted evaluations where several neurocognitive deficiencies remain undetected. As a solution, we propose using machine learning to predict the optimal order of tests for each child, reducing the number of tests required to identify the most severe neurocognitive deficiencies.
METHODS METHODS
We have compared the current clinical approach against several machine learning methods, mainly multi-target regression and label ranking methods. We have also proposed a new method that builds several multi-target predictive models and combines the outputs into a ranking that prioritizes the worse neurocognitive outcomes. We used data available at discharge, from children who participated in the PEPaNIC-RCT trial (ClinicalTrials.gov-NCT01536275), as well as data from a 2-year follow-up study. The institutional review boards at each participating site have also approved this follow-up study (ML8052; NL49708.078; Pro00038098).
RESULTS RESULTS
Our proposed method managed to outperform other machine learning methods and also the current clinical practice. Precisely, our method reaches approximately 80% precision when considering top-4 outcomes, in comparison to 65% and 78% obtained by the current clinical practice and the state-of-the-art method in label ranking, respectively.
CONCLUSIONS CONCLUSIONS
Our experiments demonstrated that machine learning can be competitive or even superior to the current testing order employed in clinical practice, suggesting that our model can be used to severely reduce the number of tests necessary for each child. Moreover, the results indicate that possible long-term adverse outcomes are already predictable as early as at ICU discharge. Thus, our work can be seen as the first step to allow more personalized follow-up after ICU discharge leading to preventive care rather than curative.

Identifiants

pubmed: 38614026
pii: S0169-2607(24)00162-7
doi: 10.1016/j.cmpb.2024.108166
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01536275']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108166

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors declare that there is no conflict of interest.

Auteurs

Felipe Kenji Nakano (FK)

KU Leuven, Campus KULAK, Department of Public Health and Primary Care, Etienne Sabbelaan 53, Kortrijk, 8500, Belgium; Itec, imec research group at KU Leuven, Etienne Sabbelaan 53, Kortrijk, 8500, Belgium. Electronic address: felipekenji.nakano@kuleuven.be.

Karolijn Dulfer (K)

Intensive Care Unit, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Doctor Molewaterplein 40, Rotterdam, 3015 GD, the Netherlands.

Ilse Vanhorebeek (I)

Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, UZ Herestraat 49, Leuven, 3000, Belgium.

Pieter J Wouters (PJ)

Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, UZ Herestraat 49, Leuven, 3000, Belgium.

Sascha C Verbruggen (SC)

Intensive Care Unit, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Doctor Molewaterplein 40, Rotterdam, 3015 GD, the Netherlands.

Koen F Joosten (KF)

Intensive Care Unit, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre, Sophia Children's Hospital, Doctor Molewaterplein 40, Rotterdam, 3015 GD, the Netherlands.

Fabian Güiza Grandas (F)

Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, UZ Herestraat 49, Leuven, 3000, Belgium.

Celine Vens (C)

KU Leuven, Campus KULAK, Department of Public Health and Primary Care, Etienne Sabbelaan 53, Kortrijk, 8500, Belgium; Itec, imec research group at KU Leuven, Etienne Sabbelaan 53, Kortrijk, 8500, Belgium.

Greet Van den Berghe (G)

Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, UZ Herestraat 49, Leuven, 3000, Belgium.

Classifications MeSH